Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FERRIC CARBOXYMALTOSE, with a corresponding US DMF Number 33038.
Remarkably, this DMF maintains an Active status since its submission on August 02, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2018, and payment made on August 13, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II